pSivida

Watertown, United States Founded: 1987 • Age: 39 yrs
Drug delivery systems
Request Access

About pSivida

pSivida is a company based in Watertown (United States) founded in 1987.. The company has 49 employees as of December 31, 2018. pSivida has completed 1 acquisition, including EyePoint Pharmaceuticals. pSivida operates in a competitive market with competitors including Rezolute, Aviceda Therapeutics, EyePoint Pharmaceuticals, Molecular Partners and CureVac, among others.

  • Headquarter Watertown, United States
  • Employees 49 as on 31 Dec, 2018
  • Stage Public
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Psivida Corp.
Operational Areas
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
    $3.1 M
    210
    as on Dec 31, 2024
  • Net Profit
    $-130.87 M
    -85
    as on Dec 31, 2024
  • EBITDA
    $-145.85 M
    -94
    as on Dec 31, 2024
  • Latest Funding Round
    $60.5 M (USD), Post-IPO

    Mar 28, 2018

  • Investors
    RA Capital

    & 2 more

  • Employee Count
    49

    as on Dec 31, 2018

  • Investments & Acquisitions
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal
People of pSivida
Headcount 50-200
Employee Profiles 72
Board Members and Advisors 14
Employee Profiles
People
Kailey Medfisch
Senior Quality Engineer
People
James Z.
Lead Complaint Specialist
People
Bridget Eastes
Controller, Director
People
Erika Boucher
IT Business Relationship Director

Unlock access to complete

Board Members and Advisors
people
David R. Guyer
Director
people
Charles Wykoff
Scientific Advisor
people
Victor Liu
Director
people
Carl D. Regillo
Chair, Scientific Advisory Board

Unlock access to complete

Funding Insights of pSivida

  • Total Funding
  • Total Rounds 4
  • Last Round Post-IPO — $60.5M
  • First Round

    (18 Jul 2012)

  • Investors Count 3
Date Amount Transaction Name Valuation Lead Investors Investors
Mar, 2018 Amount Debt – Conventional - pSivida Valuation

investors

Mar, 2018 Amount Post-IPO - pSivida Valuation

investors

Mar, 2014 Amount Post-IPO - pSivida Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in pSivida

pSivida has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include RA Capital, SWK Holdings and EW Healthcare Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Growth-stage healthcare companies are invested in by EW Healthcare Partners.
Founded Year Domain Location
Investments and advisory services are provided by the holding company.
Founded Year Domain Location
RA Capital is engaged in evidence-based investing in healthcare and life sciences.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by pSivida

pSivida has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include EyePoint Pharmaceuticals. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Acquisitions
Company Name Description Domain Location Founded Year Amount
Small molecule therapeutics for ophthalmic disorders are developed.
1987
Company Name Description Domain Location Founded Year Amount
OVO is recognized as a smart digital payment application.
2017
Bionic investment advisor platform
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014

Financial Statements - pSivida

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Psivida Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of pSivida

pSivida operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Rezolute, Aviceda Therapeutics, EyePoint Pharmaceuticals, Molecular Partners and CureVac, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Therapies for metabolic and orphan diseases are developed by Rezolute.
domain founded_year HQ Location
Biotherapeutics for glycol-immune diseases are developed across multiple therapeutic areas.
domain founded_year HQ Location
Small molecule therapeutics for ophthalmic disorders are developed.
domain founded_year HQ Location
Therapeutic solutions for diseases are developed using DARPin technology.
domain founded_year HQ Location
mRNA-based therapeutics against cancer and infectious diseases are developed.
domain founded_year HQ Location
Gene therapy solutions for retinal diseases are developed.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Psivida

Frequently Asked Questions about pSivida

When was pSivida founded?

pSivida was founded in 1987 and raised its 1st funding round 25 years after it was founded.

Where is pSivida located?

pSivida is headquartered in Watertown, United States.

Who is the current CEO of pSivida?

Paul Ashton is the current CEO of pSivida.

How many employees does pSivida have?

As of Dec 31, 2018, the latest employee count at pSivida is 49.

What is the annual revenue of pSivida?

Annual revenue of pSivida is $3.1M as on Dec 31, 2024.

What does pSivida do?

Founded in 1987 and based in Watertown, United States, pSivida operates in the biotechnology sector, focusing on sustained-release drug delivery technologies. Products such as Durasert and Tethadur are licensed to partners including Pfizer and Alimera Sciences for applications in ophthalmology. FDA-approved offerings like ILUVIEN for diabetic macular edema and Retisert for uveitis are utilized through intravitreal implants, with administration controlled for months or years.

Who are the top competitors of pSivida?

pSivida's top competitors include EyePoint Pharmaceuticals, Rezolute and Molecular Partners.

How many acquisitions has pSivida made?

pSivida has made 1 acquisition, including EyePoint Pharmaceuticals.

Who are pSivida's investors?

pSivida has 3 investors. Key investors include RA Capital, SWK Holdings, and EW Healthcare Partners.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available